ConductScience.org, home

Paper6991941

Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens.

Woods RL and 4 others. N Engl J Med, 1980. Cited by 132 papers, by iCite.

Cite this record

ConductScience Library. Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens. Papers, record 6991941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6991941

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens.
PubMed
Journal
N Engl J Med
PubMed
Year
1980
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
132
iCite
Relative citation ratio, by iCite
4.76
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Woods RLR L
2Fox RMR M
3Tattersall MHM H
4Levi JAJ A
5Brodie GNG N

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Antineoplastic AgentsMajor topic
Adult
Aged
Bone Neoplasms
Clinical Trials as Topic
Cyclophosphamide
Doxorubicin
Drug Therapy, Combination
Female
Fluorouracil
Humans
Liver Neoplasms
Lung Neoplasms
Male
Methotrexate
Middle Aged
Mitomycins
Random Allocation

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.

PMIDTitleJournalYearIn PapersSource
40242159Advancements in Diagnostics and Therapeutics for Cancer of Unknown Primary in the Era of Precision Medicine.MedComm (2020)2025https://conductscience.org/library/papers/40242159PubMed
22048624Carcinomas of an unknown primary origin--diagnosis and treatment.Nat Rev Clin Oncol2011https://conductscience.org/library/papers/22048624PubMed
20824034Carcinoma of Unknown Primary - an Orphan Disease?Breast Care (Basel)2008https://conductscience.org/library/papers/20824034PubMed
20300978Gemcitabine and cisplatin in patients with carcinoma of unknown primary site.Med Oncol2011https://conductscience.org/library/papers/20300978PubMed
19623297Metastases in the Absence of a Primary Tumor: Advances in the Diagnosis and Treatment of CUP Syndrome.Dtsch Arztebl Int2008https://conductscience.org/library/papers/19623297PubMed
12647637Adenocarcinoma of unknown primary site.Korean J Intern Med2002https://conductscience.org/library/papers/12647637PubMed
8795590How should cancer presenting as a malignant pleural effusion be managed?Br J Cancer1996https://conductscience.org/library/papers/8795590PubMed
8601568The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary.J Cancer Res Clin Oncol1996https://conductscience.org/library/papers/8601568PubMed
3933808Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin.CMAJ1985https://conductscience.org/library/papers/3933808PubMed
3791561Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3791561PubMed
2491794Phase II study of combination 4'-epidoxorubicin and mitomycin C in recurrent epithelial ovarian cancer.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2491794PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6991941

GET https://conductscience.org/api/papers/v1/6991941/authors